tacalyx
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA
tacalyx has raised €18M across 2 funding rounds from 7 investors, most recently a Seed round in Apr 2026. Based in Berlin, Germany; active in Healthtech. Data as of 28 Oct 2026.
Berlin, Germanywww.tacalyx.com ↗
Total raised
€18M
€18,000,000
Funding rounds
2
Investors
7
distinct backers
Active since
2019-10
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDtacalyx — funding by year — interactive chart.
Data table
| tacalyx — funding by year | |
|---|---|
| 2019 | €7.0M |
| 2026 | €11M |
Signals
High confidenceRaise-next likelihood43
base rate 44% for Seed
- ▼ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood19
base rate 11% (2+ rounds)
- ▲ 7y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-30 | Seed | €11M | Boehringer Ingelheim Venture Fund (BIVF),Creathor Venture,Eurazeo,High-Tech Gründerfonds (HTGF),Kurma Partners,Thuja Capital | View deal → |
| 2019-10-01 | Seed | €7.0M | Boehringer Ingelheim Venture Fund,Kurma Partners | View deal → |
Investors
7Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData